Literature DB >> 29224720

CTNNB1 mutations in basal cell adenoma of the salivary gland.

Yi-Hsuan Lee1, Wen-Chih Huang2, Min-Shu Hsieh3.   

Abstract

BACKGROUND/
PURPOSE: Basal cell adenoma (BCA) and basal cell adenocarcinoma (BCAC) are uncommon salivary gland tumors comprising proliferation of basaloid cells. Nuclear β-catenin expression and mutations in its encoding gene (CTNNB1) are reported to be specific to BCA. PIK3CA mutations are only found in BCAC not in BCA. However, in previous studies the number of cases was relatively small. The present study analyzed 44 cases of basal cell neoplasms to identify the CTNNB1 and PIK3CA mutation profiles in this rare salivary gland tumor.
METHODS: The basic clinical features and detailed histological patterns of 41 BCA and three BCAC cases were analyzed. All basal cell neoplasms and a tissue microarray of adenoid cystic carcinoma (AdCC) were tested for β-catenin immunohistochemistry. CTNNB1, PIK3CA, and CYLD mutations were detected by PCR and Sanger sequencing in each case.
RESULTS: Nuclear β-catenin expression was present in 97.6% of BCA and 66.7% of BCAC cases but not in AdCC cases. CTNNB1 mutations were found in 60% of BCA but not in BCAC. None of the tested cases had PIK3CA mutations. CTNNB1 mutation trended to be more common in those cases having a predominant tubular or tubulotrabecular patterns (p = 0.059).
CONCLUSION: β-catenin immunohistochemistry is very useful for the differential diagnosis between BCA/BCAC and AdCC. CTNNB1 mutations are common in BCA, especially those with tubular or tubulotrabecular patterns.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Basal cell adenoma; Beta catenin; CTNNB1; Salivary glands

Mesh:

Substances:

Year:  2017        PMID: 29224720     DOI: 10.1016/j.jfma.2017.11.011

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  5 in total

1.  A retrospective study of 30 basal cell adenomas of the salivary gland in a Brazilian population and literature review.

Authors:  Mirna Scalon Cordeiro; Silas Antonio Juvencio de Freitas Filho; João Paulo Silva Servato; Ana Lúcia Amaral Eisenberg; Fernando Luiz Dias; Paulo Rogério de Faria; Adriano Mota Loyola; Sérgio Vitorino Cardoso
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-04       Impact factor: 2.503

2.  Assessment of CTNNB1 gene mutations and β-catenin immunoexpression in salivary gland pleomorphic adenomas and adenoid cystic carcinomas.

Authors:  Roberta Barroso Cavalcante; Cassiano Francisco Weege Nonaka; Hellen Bandeira de Pontes Santos; Silvia Helena Barem Rabenhorst; Leão Pereira Pinto; Lélia Batista de Souza
Journal:  Virchows Arch       Date:  2018-03-26       Impact factor: 4.064

3.  Analysis of the Differentially Expressed Genes Induced by Cisplatin Resistance in Oral Squamous Cell Carcinomas and Their Interaction.

Authors:  Hua-Tao Wu; Wen-Tian Chen; Guan-Wu Li; Jia-Xin Shen; Qian-Qian Ye; Man-Li Zhang; Wen-Jia Chen; Jing Liu
Journal:  Front Genet       Date:  2020-01-23       Impact factor: 4.599

4.  SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets.

Authors:  Sandra N Freiberger; Muriel Brada; Christine Fritz; Sylvia Höller; Alexander Vogetseder; Milo Horcic; Michel Bihl; Michal Michal; Martin Lanzer; Martin Wartenberg; Urs Borner; Peter K Bode; Martina A Broglie; Tamara Rordorf; Grégoire B Morand; Niels J Rupp
Journal:  Neoplasia       Date:  2021-04-18       Impact factor: 5.715

5.  Targeted RNA sequencing in the routine clinical detection of fusion genes in salivary gland tumors.

Authors:  Justin Bubola; Christina M MacMillan; Elizabeth G Demicco; Rose A Chami; Catherine T-S Chung; Iona Leong; Paula Marrano; Zeynep Onkal; David Swanson; Brandon M Veremis; Ilan Weinreb; Lei Zhang; Cristina R Antonescu; Brendan C Dickson
Journal:  Genes Chromosomes Cancer       Date:  2021-07-08       Impact factor: 4.263

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.